{"id":"W2942397799","doi":"10.1097/01.ju.0000555927.90500.b0","title":"MP34-20 METASTASIS-FREE SURVIVAL (MFS) IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS (PTS) WITH PROSTATE-SPECIFIC ANTIGEN (PSA) DECLINE TO < 0.2 NG/ML FOLLOWING APALUTAMIDE (APA) TREATMENT: POST HOC RESULTS FROM THE PHASE 3 SPARTAN STUDY","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Urology; Prostate-specific antigen; Oncology; Internal medicine; Metastasis; Prostate; Antigen; Cancer; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00130943,0.0003291364,0.0005928212,0.0002149433,0.0001807072,0.0003948164,0.0003063175,0.0004198013,0.001877946],"category_scores_gemma":[0.0008839028,0.0001533625,0.0009621727,0.0002060534,0.0002928975,0.0003873805,0.0002126099,0.00108401,0.0002490943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003527336,"about_ca_system_score_gemma":0.0006221703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001068837,"about_ca_topic_score_gemma":0.003204773,"domain_scores_codex":[0.9996892,0.0001668012,0.00001323434,0.00002972259,0.0000574742,0.00004363987],"domain_scores_gemma":[0.9993717,0.0001695384,0.0001559453,0.00004856142,0.00007056049,0.0001837312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5988676,0.01965426,0.06958518,0.000952888,0.002793182,0.0002008186,0.0002316627,0.002929418,0.02307403,0.0002867874,0.02408056,0.2573436],"study_design_scores_gemma":[0.1204525,0.5085114,0.3465227,0.0001331565,0.00294898,0.0003890649,0.0001989217,0.002053713,0.008405803,0.0003385138,0.009969119,0.00007611574],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942666,0.00273576,0.00009973338,0.0003431375,0.00007915561,0.0002016407,0.0008801356,0.00001777929,0.00137607],"genre_scores_gemma":[0.9923343,0.002240203,0.00035836,0.0005158067,0.0001529637,0.0002457801,0.001852169,0.0000126409,0.002287663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001877946,"threshold_uncertainty_score":0.006924987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02707255799377112,"score_gpt":0.3037075249251588,"score_spread":0.2766349669313877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}